arimoclomol has been researched along with pimagedine in 1 studies
| Studies (arimoclomol) | Trials (arimoclomol) | Recent Studies (post-2010) (arimoclomol) | Studies (pimagedine) | Trials (pimagedine) | Recent Studies (post-2010) (pimagedine) |
|---|---|---|---|---|---|
| 34 | 4 | 22 | 2,162 | 18 | 390 |
| Protein | Taxonomy | arimoclomol (IC50) | pimagedine (IC50) |
|---|---|---|---|
| Nitric oxide synthase, brain | Homo sapiens (human) | 5.9 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 4.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bíró, K; Jednákovits, A; Kukorelli, T; Kürthy, M; Mogyorósi, T; Nagy, K; Tálosi, L | 1 |
1 other study(ies) available for arimoclomol and pimagedine
| Article | Year |
|---|---|
Effect of BRX-220 against peripheral neuropathy and insulin resistance in diabetic rat models.
Topics: Animals; Diabetic Neuropathies; Guanidines; Hydroxylamines; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Pioglitazone; Rats; Rats, Wistar; Rats, Zucker; Streptozocin; Thiazoles; Thiazolidinediones | 2002 |